Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02871921 · ClinicalTrials.gov registry record · NA
Internet-based Conversational Engagement Clinical Trial
A NA study of Aging and Mild Cognitive Impairment, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 186
- Enrollment target
- 2
- Study locations
NCT02871921 is a NA study of Aging and Mild Cognitive Impairment that has completed, run by Massachusetts General Hospital. The registered enrollment target is 186 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT02871921, a NA study of Aging and Mild Cognitive Impairment, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 186 participants
- Enrollment target
- 2
- Study locations
Study Summary
The study aims to randomize 320 (160 Caucasian, 160 African American) socially isolated adults 75+ years old (50:50 split between those with normal cognition and mild cognitive impairment (MCI)) recruited from the community to either the Video Chat Group or the Control Group. The participants in the Video Chat Group will receive a computer and internet service for the duration of the study, which they will use to video chat with study staff for 30 minutes/day 4x/week for 6 months (high dose), and then 2x/week for an additional 6 months (maintenance dose). The efficacy examination of the maintenance dose is limited to an exploratory aim. Both intervention and control groups will have a brief (about 10 minutes) telephone check-in with study staff once per week. In-home testing will occur at Baseline and 6 months. A sub-sample of participants\*\* will be assessed at 12 months (exploratory) after additional 6 months of maintenance dose. All participants at OHSU will have their medication compliance tracked using an electronic medication monitoring device and participants at both OHSU and UM will have MRIs at Baseline and 6 months, if they are able to safely receive MRIs. Participants at both sites will contribute saliva for genetic testing (optional consent), and all video chat and neuropsychological assessment sessions will be recorded for speech and language analysis (consent required for participation).
Conditions Studied
Interventions
- BEHAVIORAL Conversational Engagement
Study Locations (2)
Massachusetts
- Massachusetts General Hospital - Boston
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2021-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02871921
The ClinicalTrials.gov registry entry for NCT02871921 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 186 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (92% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Aging appearing as the primary indexed condition, and to 1 intervention - of which Conversational Engagement is the first listed.
NCT02871921 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Michigan.
Frequently Asked Questions
What is clinical trial NCT02871921 about?
NCT02871921 is a clinical study titled "Internet-based Conversational Engagement Clinical Trial". The study aims to randomize 320 (160 Caucasian, 160 African American) socially isolated adults 75+ years old (50:50 split between those with normal cognition and mild cognitive impairment (MCI)) recruited from the community to either the Video Chat Group or the Control Group. The participants in the...
What is the current status of trial NCT02871921?
This trial is currently completed. It is a NA study. The enrollment target is 186 participants. The study started on 2018-06-01. Estimated completion is 2021-08-31.
What conditions does trial NCT02871921 study?
This clinical trial studies the following conditions: Aging, Mild Cognitive Impairment.
What interventions are being tested in trial NCT02871921?
The interventions under investigation include: Conversational Engagement (BEHAVIORAL).
Who is sponsoring clinical trial NCT02871921?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02871921 being conducted?
This trial has 2 study locations across Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Using Nicotine to Reverse Age-related Auditory Processing Deficits
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
-
Studying the Effects of Digital Interventions on Cognition, Wellbeing, Stress, and Sleep in Older Adults
RECRUITING · NA
-
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.